Shinichiro Fuse - Profile and Investment Details

Investor Profile

Shinichiro Fuse is a Venture Capital, Private Equity Firm, Investment Partner based in Cambridge, Massachusetts, United States with a diverse investment portfolio that includes companies such as CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology, CODA Biotherapeutics, Tetherex Pharmaceuticals, Motus TherapeuticsAstute Medical, Clinical Ink, iPierian, Cullinan Oncology, TriVascular, Frontier Medicines, Aktis Oncology, Entrada Therapeutics, Atopix Therapeutics, Trishula Therapeutics, Aratana Therapeutics, Harpoon Therapeutics, Umoja Biopharma, Radius Health, Oncorus, Proteon Therapeutics, Rhythm Metabolic, ElevateBio, MPM Capital, Valeritas, Bluebird Bio, Werewolf Therapeutics, Repare Therapeutics, Semma Therapeutics, Nevro, Kalidex Pharmaceuticals, Chiasma, 23andMe, Selexys Pharmaceuticals Corporation, Iconic Therapeutics, Dyne Therapeutics, Blade Therapeutics, Theraclone Sciences, Vascular Pharmaceuticals, Celladon, Raze Therapeutics, Conatus Pharmaceuticals, Twentyeight-Seven Therapeutics, Amphivena Therapeutics, True North Therapeutics, SiO2 Medical Products, Orna Therapeutics, Inc., Cerecor, TCR2, arGEN-X, Triplet Therapeutics, NeoVista, Tizona Therapeutics, Sideris Pharmaceuticals, ReCode Therapeutics, BioIntervene, Rhythm Pharmaceuticals, ITeos Therapeutics, Orna Therapeutics, IOmx Therapeutics, Syndax Pharmaceuticals, . Over time, Shinichiro Fuse has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Shinichiro Fuse is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Genetics, Equities, Investment Management, Strategic Partnerships, Life Science, Emerging Markets, Portfolio Management, Information Technology (IT), Customer Success, Finance, Biotechnology, Genomics, Innovation, Social Impact, Developer Tools, Medical, B2B, Real Estate, Therapeutics, Emergency Medicine, Pharmaceuticals, Risk Management may find it worthwhile to explore potential connections with Shinichiro Fuse, as their portfolio suggests a familiarity and interest in this area.

Understanding Shinichiro Fuse’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.